Skip to main content
. 2020 Feb 20;17(4):1373. doi: 10.3390/ijerph17041373

(b)

Pathway Total Expected Hits p-Value
Pathways in cancer 310 5.37 20 1.66E-07
Chronic myeloid leukemia 73 1.26 8 3.07E-05
MAPK signaling pathway 265 4.59 15 3.67E-05
Maturity onset diabetes of the young 24 0.415 5 4.50E-05
Pertussis 52 0.9 6 2.41E-04
Transcriptional misregulation in cancer 19 0.329 4 2.65E-04
Acute myeloid leukemia 57 0.987 6 4.00E-04
HTLV-I infection 199 3.44 11 5.53E-04
Prostate cancer 87 1.51 7 6.87E-04
Thyroid cancer 28 0.485 4 1.24E-03